Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Total Liabilities (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Total Liabilities for 4 consecutive years, with $10.5 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities fell 35.9% to $10.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.5 million through Dec 2025, down 35.9% year-over-year, with the annual reading at $10.5 million for FY2025, 35.9% down from the prior year.
  • Total Liabilities for Q4 2025 was $10.5 million at Spruce Biosciences, up from $9.9 million in the prior quarter.
  • The five-year high for Total Liabilities was $31.1 million in Q1 2023, with the low at $8.6 million in Q2 2025.
  • Average Total Liabilities over 4 years is $18.3 million, with a median of $16.4 million recorded in 2024.
  • The sharpest move saw Total Liabilities surged 111.03% in 2023, then plummeted 51.22% in 2024.
  • Over 4 years, Total Liabilities stood at $17.2 million in 2022, then soared by 59.87% to $27.4 million in 2023, then plummeted by 40.27% to $16.4 million in 2024, then tumbled by 35.9% to $10.5 million in 2025.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $10.5 million, $9.9 million, and $8.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.